Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 14, Issue 10, 2012, Pages 901-909

  Freemantle, N ^a   Balkau, B ^b   Danchin, N ^c   Wang, E ^d   Marre, M ^e   Vespasiani, G ^f   Kawamori, R ^g   Home, P D ^h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SANOFI   (France)

^e BICHAT HOSPITAL   (France)

^f Madonna del Soccorso Hospital   (Italy)

^g JUNTENDO UNIVERSITY   (Japan)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CREDIT study; Insulin regimens; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DIABETIC PATIENT; DISEASE DURATION; DRUG DOSE REGIMEN; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN TREATMENT; JAPAN; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL PRACTICE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PHYSICIAN; POPULATION RESEARCH; PRIMARY MEDICAL CARE; RISK FACTOR; RURAL AREA; SELF MONITORING; SMOKING; TREATMENT DURATION; URBAN AREA;

EID: 84865984495     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01613.x     Document Type: Article

References (15)

1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
2. Ray KK, Seshasai SR, Wijesuriya S et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-1772.
3. Turnbull FM, Abraira C, Anderson RJ et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288-2298.
4. Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009; 52: 17-30.
5. International Diabetes Federation. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. Brussels: Brussels International Diabetes Federation, 2005.
6. Rodbard HW, Blonde L, Braithwaite SS et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13 (Suppl. 1): 1-68.
7. Crasto W, Jarvis J, Khunti K, Davies MJ. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes. Postgrad Med J 2009; 85: 257-267.
8. Grant RW, Wexler DJ, Watson AJ et al. How doctors choose medications to treat type 2 diabetes. A national survey of specialists and academic generalists. Diabetes Care 2007; 30: 1448-1453.
9. Shestakova M, Bech OM, Momani MS. Study design and baseline characteristics of patients in the PRESENT study. Diabetes Res Clin Pract. 2008; 81 (Suppl. 1): S3-9.
10. Valensi P, Benroubi M, Borzi V et al. The IMPROVE study-a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract 2008; 62: 1809-1819.
11. Peyrot M, Rubin RR, Lauritzen T et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673-2679.
12. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27: 1535-1540.
13. Yoshinaga H, Kosaka K. Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 1999; 44: 129-136.
14. Arai K, Matoba K, Hirao K et al. Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15, 652 patients. Endocr J 2010; 57: 499-507.
15. Ligthelm RJ, Borzì V, Gumprecht J et al. Importance of observational studies in clinical practice. Clin Ther 2007; 29: 1284-1292.